Profile
PBLA VRTX REGN ALNY SGEN ARGX
Company Name Panbela Therapeutics, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc. Seagen Inc. argenx SE
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $776.77K $117.98B $57.12B $43.28B $43.15B $33.34B
Employees 0.01K 6.10K 15.16K 2.23K 3.26K 1.60K
CEO Jennifer K. Simpson CRNP, M.S.N., Reshma Kewalramani FASN, Leonard S. Schleifer Yvonne L. Greenstreet David R. Epstein Timothy Van Hauwermeiren EMBA,
Ratings
PBLA VRTX REGN ALNY SGEN ARGX
Quant Rating Score 2 2 4 1 3 2
Quant Rating Sell Sell Buy Strong Sell Neutral Sell
Trading
PBLA VRTX REGN ALNY SGEN ARGX
Last Close $0.158 $466.36 $547.75 $317.5 $228.74 $538.64
High 52 $1.11 $516.74 $1201.76 $331.91 $228.74 $671.75
Low 52 $0.16 $396.64 $482.92 $224.58 $228.74 $457.68
Price vs. 52 Week High -85.77 % -9.75 % -54.42 % -4.34 % 0 % -19.82 %
Price vs. 52 Week Low -1.25 % 17.58 % 13.42 % 41.38 % 0 % 17.69 %
Total Return
PBLA VRTX REGN ALNY SGEN ARGX
1 Month Return -37.8 % 4.53 % 5.78 % 4.44 % 0 % -7.71 %
3 Month Return -49.03 % -3.3 % -4.93 % 30.53 % 0 % -4.47 %
6 Month Return -56.11 % 13.16 % -25.33 % 31.99 % 0 % -17.04 %
9 Month Return -60.5 % -0.34 % -45.88 % 17.2 % 0 % 3.48 %
YTD Return -57.3 % 15.81 % -23.1 % 34.93 % 0 % -12.42 %
1 Year Return -55.06 % -4.04 % -48.03 % 24.64 % 0 % 17.69 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
PBLA VRTX REGN ALNY SGEN ARGX
Dividend Yield Percentage (TTM) - - 0.33 % - - -
Dividend Paid and Capex Coverage Ration (TTM) - -3.53 % 3.85 % -1.49 % -5.87 % -44.32 %
Dividend Per Share (TTM) - - 1.76 % - - -
Payout Ratio (TTM) - - 2.08 % - - -
Profitability
PBLA VRTX REGN ALNY SGEN ARGX
Gross Profit Margin TTM - 86.03 % 84.94 % 86.01 % 79.1 % 46.33 %
Return on Assets TTM -539.96 % -4.32 % 11.98 % -6.4 % -16.61 % 13.45 %
Return on Equity TTM 304.71 % -6.25 % 14.77 % -509.33 % -20.8 % 16.83 %
Return on Capital Employed TTM 241.77 % -3.89 % 11.35 % -3.68 % -21.46 % -0.5 %
Net Income Per EBT TTM 99.44 % 329.41 % 90.27 % 75.89 % 101.33 % 25990.14 %
EBT Per Ebit TTM 77.51 % 40.44 % 129.3 % 308.03 % 98.26 % -11.64 %
EBIT Per Revenue TTM - -6.69 % 27.37 % -4.91 % -31.24 % -1.24 %
Cash Flow To Debt Ratio TTM -243.56 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Receivables Turnover TTM - 6.15 2.53 5.62 3.91 2.46
Payables Turnover TTM 2.65 3.49 3.01 3.37 1.97 2.39
Inventory Turnover TTM - 1.14 0.66 5.01 0.96 2.93
Fixed Asset Turnover TTM - 421.34 % 300.07 % 337.41 % 665.41 % 4929.48 %
Asset Turnover TTM - 48.51 % 37.52 % 55.72 % 53.41 % 35.83 %
Operating Cash Flow Per Share TTM -3.21 -3.82 37.05 -0.35 -2.46 -1.07
Free Cash Flow Per Share TTM -3.21 -4.9 28.3 -0.58 -2.88 -1.09
Cash Per Share TTM 2.92 % 2413.86 % 7825.12 % 2024.29 % 939.52 % 4688.94 %
Operating Cash Flow Sales Ratio TTM - -8.83 % 28.06 % -1.92 % -23.12 % -3.54 %
Free Cash Flow Operating Cash Flow Ratio TTM 100 % 128.33 % 76.4 % 167.11 % 117.04 % 102.26 %
Cash Flow Coverage Ratios TTM -243.56 % -59.44 % 146.15 % -3.47 % -1043.73 % -201.37 %
Price To Free Cash Flows Ratio TTM -0.05 -93.78 18.91 -574.08 -81.26 -431.71
Price To Operating Cash Flows Ratio TTM -0.05 -120.39 14.52 -954.11 -93.1 -512.95
Price Cash Flow Ratio TTM -0.05 -120.39 14.52 -954.11 -93.1 -512.95
Income Statement (TTM)
PBLA VRTX REGN ALNY SGEN ARGX
Revenue $0B $11.02B $14.2B $2.25B $1.96B $2.19B
Gross Profit $-0.03B $9.49B $12.23B $1.92B $1.55B $1.96B
Gross Profit Ratio 0% 86.11% 86.13% 85.62% 79.1% 89.62%
EBITDA $-0.05B $0.49B $5.32B $-0.18B $-0.62B $0.11B
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $0.83B
EPS Diluted -232429.55 -2.08 38.34 -2.16 -3.3 12.78
Balance Sheet (MRQ)
PBLA VRTX REGN ALNY SGEN ARGX
Long Term Debt $0B $1.66B $1.98B $0B $0.04B $0.03B
Total Liabilities $0.02B $6.12B $8.41B $4.17B $0.87B $0.7B
Total Equity $-0B $16.41B $29.35B $0.07B $2.8B $5.5B
Total Investments $0B $6.65B $15.42B $1.73B $1.42B $1.93B
Total Debt $0.01B $1.75B $2.7B $1.3B $0.04B $0.04B
Total Assets $0.01B $22.53B $37.76B $4.3B $3.67B $6.2B
Cash Flow Statement (TTM)
PBLA VRTX REGN ALNY SGEN ARGX
Net Income $-0.03B $-0.54B $4.41B $-0.28B $-0.61B $-0.02B
Inventory $0B $-0.52B $-0.62B $0.01B $-0.23B $-0.09B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.03B $-0.49B $4.42B $-0.01B $-0.45B $-0.08B
Capital Expenditure $0B $-0.3B $-0.76B $-0.03B $-0.08B $-0.07B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 41.49
AARD Aardvark Therapeutics, Inc. Common Stock 12.74
ABCL AbCellera Biologics Inc. 4.225
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.83
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.245
ABPWW 0.02
ABSI Absci Corporation 2.83
ABUS Arbutus Biopharma Corporation 3.325
ABVC ABVC BioPharma, Inc. 4.685
ABVX Abivax SA American Depositary Shares 8.26
ACAD ACADIA Pharmaceuticals Inc. 21.545
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.7114
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 2.365
ACIU AC Immune SA 2.07
ETFs With Exposure to PBLA
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 197.68
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 148.65
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 148.66
VEMPX Vanguard Extended Market Index InstlPlus 0 366.84
Unlock